| Type | Filed | Filer | Subject | Shares Owned | Percent Owned | |
|---|---|---|---|---|---|---|
| SC 13G/A | 2024-02-14 | Darwin Global Management, Ltd. | TG THERAPEUTICS, INC. | 4,046,598 | 2.7% | EDGAR |
| SC 13G/A | 2024-02-13 | VANGUARD GROUP INC | TG THERAPEUTICS, INC. | 13,670,944 | 9.0% | EDGAR |
| SC 13G/A | 2024-01-26 | BlackRock Inc. | TG THERAPEUTICS, INC. | 10,768,163 | 7.1% | EDGAR |
| SC 13G/A | 2024-01-25 | STATE STREET CORP | TG THERAPEUTICS, INC. | - | 5.4% | EDGAR |
| SC 13G | 2023-04-03 | Darwin Global Management, Ltd. | TG THERAPEUTICS, INC. | 10,451,241 | 7.1% | EDGAR |
| SC 13G/A | 2023-02-09 | FMR LLC | TG THERAPEUTICS, INC. | 7,188,862 | 4.9% | EDGAR |
| SC 13G/A | 2023-02-09 | VANGUARD GROUP INC | TG THERAPEUTICS, INC. | 15,502,764 | 10.7% | EDGAR |
| SC 13G/A | 2023-02-03 | STATE STREET CORP | TG THERAPEUTICS, INC. | - | 7.2% | EDGAR |
| SC 13G/A | 2023-02-01 | BlackRock Inc. | TG THERAPEUTICS, INC. | 9,132,890 | 6.3% | EDGAR |
| SC 13G/A | 2022-10-11 | VANGUARD GROUP INC | TG THERAPEUTICS, INC. | 14,746,392 | 10.2% | EDGAR |
| SC 13G/A | 2022-07-11 | FMR LLC | TG THERAPEUTICS, INC. | 8,054,461 | 5.6% | EDGAR |
| SC 13G/A | 2022-02-10 | VANGUARD GROUP INC | TG THERAPEUTICS, INC. | 12,091,437 | 8.5% | EDGAR |
| SC 13G/A | 2022-02-09 | FMR LLC | TG THERAPEUTICS, INC. | 20,721,431 | 14.5% | EDGAR |
| SC 13G/A | 2022-02-01 | BlackRock Inc. | TG THERAPEUTICS, INC. | 8,902,165 | 6.2% | EDGAR |
| SC 13G/A | 2021-02-16 | GREAT POINT PARTNERS LLC | TG THERAPEUTICS, INC. | 0 | 0.0% | EDGAR |
| SC 13G/A | 2021-02-10 | RA CAPITAL MANAGEMENT, L.P. | TG THERAPEUTICS, INC. | 8,685,471 | 6.4% | EDGAR |
| SC 13G/A | 2021-02-10 | RA CAPITAL MANAGEMENT, L.P. | TG THERAPEUTICS, INC. | 6,361,123 | 4.7% | EDGAR |
| SC 13G | 2021-02-10 | VANGUARD GROUP INC | TG THERAPEUTICS, INC. | 10,970,863 | 8.1% | EDGAR |
| SC 13G/A | 2021-02-08 | FMR LLC | TG THERAPEUTICS, INC. | 14,827,136 | 11.0% | EDGAR |
| SC 13G/A | 2021-02-01 | BlackRock Inc. | TG THERAPEUTICS, INC. | 8,556,286 | 6.3% | EDGAR |